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Introduction: Synthetic mesh has been used traditionally to repair abdominal wall defects, but its use is limited in
the case of bacterial contamination. New biological materials are now being used successfully for delayed primary
closure of contaminated abdominal wall defects. The costs of biological materials may prevent surgeons from using
them. We compared the conventional staged repair of contaminated abdominal wall defects with a single-stage
procedure using a non-crosslinked porcine acellular dermal matrix.
Methods: A total of 14 cases with Grade 3 contaminated abdominal wall defects underwent delayed primary
closure of the abdomen using a non-crosslinked porcine acellular dermal matrix (Strattice™ Reconstructive Tissue
Matrix, LifeCell Corp., Branchburg, NJ, USA). The results were compared with a group of 14 patients who had
received conventional treatment for the repair of contaminated abdominal wall defects comprising a staged repair
during two separate hospital admissions employing synthetic mesh. Treatment modalities, outcomes, and costs
were compared.
Results: In all cases treated with delayed primary closure employing non-crosslinked porcine acellular dermal
matrix, there were no complications related to its use. Two patients died due to unrelated events. Although
treatment costs were estimated to be similar in the two groups, the patients treated with porcine acellular dermal
matrix spent less time as an inpatient than those receiving conventional two-stage repair.
Conclusions: Delayed primary closure of contaminated abdominal wall defects using a non-crosslinked porcine
acellular dermal matrix may be a suitable alternative to conventional staged repair. In our patients, it resulted in
early restoration of abdominal wall function and shorter hospitalization. The costs for treating contaminated
abdominal wall defects using porcine acellular dermal matrix during a single hospital admission were not higher
than costs for conventional two-stage repair. Further randomized studies are needed to expand upon these findings.
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Table 1 Patient diagnosis on admission
Group 1 Group 2
Perforated appendicitis 1 3
Acute cholecystitis 1
Incisional hernia with fistula 1
Infection of synthetic mesh 1
Vascular procedure 1
Ileus +/− intra-abdominal abscess 2
Planned colorectal procedure 3 3
Crohn’s disease 1 1
Diverticulitis/intestinal perforation 6 4
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The reconstruction of simple abdominal wall defects can
be challenging, but when the defects are contaminated,
infected, very large, or have recurred, a durable functional
reconstruction can be difficult to achieve. The most com-
mon abdominal wall defects are incisional or recurring in-
cisional hernias, but defects may also result from trauma,
extensive tumor resection, or necrotizing infection in the
abdominal wall. In 2004, a study recorded a failure rate of
75 percent for suture repairs of simple incisional hernias
after an observation period of 10 years [1]. The results of a
prospective, randomized, multicenter trial in 2000 showed
that incisional hernias should always be repaired with a
synthetic mesh [2]. However, failure rates of repairs
employing synthetic mesh are quite high, with one study
showing a failure rate of 23 percent after three years
and 35 percent after 10 years [3]. The authors also re-
ported that after each repair, the risk of failure increased
[3]. The main reason for failure seems to be poor tech-
nique. Another very serious reason for the failure seems
to be infection, which has been identified by multivariate
analysis to be a highly significant factor for the recurrence
of incisional hernias [2].
Even when placed into sterile tissue, synthetic mesh
may shrink, migrate, or cause adhesions, fistulae, and
pain as a result of ongoing chronic inflammation [4-6].
There is evidence that synthetic mesh should not be
used in the presence of bacterial contamination or infec-
tion [7]. Mesh infection may lead to the formation of
fistulae or even mesh extrusion, and can only be treated
by radical removal of the mesh. The results of a meta-
analysis revealed that after an initial successful implant-
ation of conventional heavyweight synthetic mesh into
contaminated abdominal wall defects, 90 percent had to
be explanted [8]. Today, the evidence is growing, suggesting
that modern lightweight meshes behave more favorably in
the face of contamination. A recent, a retrospective, single-
institution study of the use of synthetic mesh in con-
taminated fields showed no increased risk of infection
or gastrointestinal fistulae [9]. However, this approach
remains controversial, and prospective randomized studies
are needed to provide further evidence.
In Europe, the traditional strategy used to close an
infected or contaminated abdominal wall defect is a two-
stage procedure requiring two separate hospital admis-
sions. The principles are to control the intra-abdominal
complication and then deal with the infection in the
plane of the abdominal wall. It may be necessary to re-
duce the bioburden, for example by sharp debridement
and the use of negative pressure wound therapy (NPWT).
In some cases the patient can be managed with a laparost-
omy alone. In some cases the bowel is allowed to granu-
late with or without the use of a resorbable mesh. After a
short period, the defect is covered with a split-thicknessskin graft or the skin is closed over the defect and the pa-
tient is discharged. Without a functional abdominal wall,
the patient has a hernia by definition. This requires further
surgical intervention three to 18 months following the
initial procedure to repair the hernia as part of a planned
abdominal reconstruction.
There have been a number of reports [10] on the use
of biological materials derived from human or animal
sources for the delayed primary closure of these high-
risk contaminated or infected abdominal wall defects.
Since 2009, a structurally intact, non-crosslinked porcine
acellular dermal matrix (PADM) has been available in
Europe and marketed under the trade name Strattice™
Reconstructive Tissue Matrix (LifeCell Corp., Branch-
burg, NJ, USA). The biological characteristics of this
PADM may facilitate tissue regeneration by encouraging
revascularization and repopulation of host cells, while
minimizing the risk of encapsulation and fibrotic tissue
formation [11].
The aim of this article is to report our experience
using PADM for the delayed primary repair of contami-
nated abdominal wall defects and to compare these cases
to a historic, previously treated group who had received
conventional treatment of their contaminated abdominal
wall defect during their initial hospital admission and a
planned hernia repair with lightweight synthetic mesh at
a later stage during a second hospital admission.
Results
The male-to-female ratio in the two study populations
was similar. The average age at the time of the repair was
69.1 years (range 41 to 88 years) in Group 1 and 66.5 years
(range 47 to 82 years) in Group 2. Both groups included
patients with minor (perforated appendicitis, cholecystitis,
stoma reversal) and major (intestinal perforation, major
colorectal procedures) problems on admission (Table 1).
Emergency surgery was required in eight patients in
Group 1 and seven in Group 2. The average body mass
index (BMI) was five points higher in Group 2 (30kg/m2)
compared with Group 1 (25kg/m2); other comorbidities
Table 3 Main operative procedures carried out
Group 1 Group 2
Appendectomy 1 3
Cholecystectomy 1
Bowel resection 9 9
Excision of infected mesh 1
Incisional hernia repair 1
Parastomal hernia repair 1
Bifurcated aortic graft 1
Adhesiolysis/drainage of abscess 1
Table 4 Postoperative course
Group 1 Group 2
Abdominal wall infection as a 9 11
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groups, and many patients had multiple risk factors for
infection (Table 2).
The extent of surgery carried out was comparable in
both groups. Nine patients required bowel resection in
each group (Table 3). The postoperative course for both
groups is shown in Table 4. Seven patients in Group 1
and eight patients in Group 2 required treatment of
peritonitis. Nine patients in Group 1 and 11 patients in
Group 2 had an abdominal wall infection. Swabs from
abdominal wall defects were cultured at initial surgery
and a wide spectrum of bacteria were detected in both
groups (Table 5). Both groups were comparable regard-
ing preoperative American Society of Anesthesiologists
(ASA) score, average number of days of intensive care
treatment, number of surgical procedures, and number
of NPWT dressing changes.
Repair of Grade 3 contaminated abdominal wall de-
fects with PADM was successful in all cases in Group 1
at a median of 20 days after admission (Table 6). Median
size of the abdominal wall defects in Group 1 was 75cm2
(range 45 to 250cm2). Median PADM size was 112cm2
(range 112 to 320cm2). There was one onlay repair of an
incarcerated parastomal hernia. Eleven patients received
intraperitoneal (three patients) or retrorectus sublay
(eight patients) placement of PADM beneath the muscle.
Reconstruction of the midline was the goal in all midline
incisions and was carried out using component separation
to advance the rectus complex medially in two patients
with severely retracted fascial edges in the presence of a
frozen abdomen (Figures 1 and 2). In non-midline inci-
sions, the fascial edges were also brought together. In one
case of a right upper-quadrant incision, PADM was placed
into an intraperitoneal sublay position, and in two cases
of Pfannenstiel incisions, PADM was placed beneath the
ventral sheath of the rectus muscle.
The approximation of the fascial edges could not be
achieved in one patient due to an extensive full-thickness
excision of the fascia, muscle, and skin. In addition, thereTable 2 Comorbid conditions increasing the risk for
wound infection
Group 1 Group 2
Average body mass index 25 30
Obese >30kg/m2 1 3
Smoker 2
Diabetes 2 1
History of soft tissue infection 2 3
Hypoxemia 1 1
Renal insufficiency 1 0
Corticosteroid therapy 1 1
Benign prostate hyperplasia 2was insufficient overlap due to the unavailability of an
adequately sized piece of PADM at the time of surgery,
resulting in a failure to achieve a sufficiently wide overlap
when covering the defect. This patient underwent the
same repair procedure twice, the first time below the um-
bilicus and the second time above it. The indication for
surgery each time was the removal of one or more me-
tastases. At re-operation nine months after the first re-
pair, adequate mechanical stability of the abdominal wall
remained. A computed tomography (CT) scan showed the
PADM in place and physically closing the defect (Figure 3).
A biopsy from the middle of the PADM nine months after
implantation showed good ingrowth of host fibroblast and
development of blood vessels in the PADM (Figure 4).
However, at 12 months the patient developed ascites due
to tumor progression and a recurrence was detected in
the area of the midline repair below the umbilicus where
the bridging had been carried out.
There were two intraoperative small bowel lesions in
Group 1 patients during the repair that did not lead to
postoperative infection. One patient treated for coloncomplication of primary surgery
Peritonitis 7 8
Preoperative ASA score 1.9 2.1
Mean days in ICU 7.6 (range 0–41) 9.3 (range 0–45)
Mean number of surgical
procedures
3.0 (range 1–9) 3.2 (range 1–10)
Mean number of NPWT dressing
changes
1.2 (range 0–3 ) 1.0 (range 0–7)
Mean number of days in-hospital
stay
27.2 (range 9–70) 26.1 (range 7–70)
Hernia on discharge first admission 0 4
Removal of mesh or PADM 0 0
Rate of recurrence at one year 1 (7.1%) 1 (7.1%)
ASA, American Society of Anesthesiologists; NPWT, negative pressure wound
therapy; PADM, porcine acellular dermal matrix; ICU, intensive care unit.
Table 5 Micro-organisms cultured from abdominal wound
swabs
Group 1 Group 2
Streptococcus 1 1
Staphylococcus epidermidis 1 1
Staphylococcus aureus 1 1
Enterococcus 1 1
Escherichia coli 2 1
Klebsiella 1 2
Proteus mirabilis 1
Citrobacter freudii 1 1
Morganella morgagni 1
Seratia marcenscens 1
No growth 2 2
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volving the PADM that resolved without PADM removal.
In one patient, a postoperative seroma was treated surgi-
cally three weeks after repair with PADM. Another patient
on oral anticoagulants suffered a hemorrhage 10 days after
surgery (Table 7).
One 78-year-old patient died from pneumonia three
weeks after retrorectus sublay repair of a burst abdomen
following emergency right colectomy for ischemic colon
necrosis. One 88-year-old patient was admitted for in-
carcerated and perforated bowel in a parastomal hernia
and died from persisting systemic sepsis. One 80-year-
old patient died four months after hernia repair during
cardiac surgery for four valve replacements. At that
time, there was no sign of recurrence in this patient. In
all three cases, local wound healing of the hernia repair
had been uneventful.
In Group 2, the repair of Grade 3 contaminated ab-
dominal wall defects during the first hospital admission
was carried out by direct suture or by simply closing the
skin over the bowel, as was done in four patients. These
four patients left the hospital with a hernia by definition.
At a median of approximately one year later (Table 6),
patients presented with hernia defects measuring a
median of 150cm2 (range 15 to 400cm2). In 10 patients,
fascial closure was achieved without special measures.
Component separation was used twice to accomplish
midline closure. Synthetic mesh with a median size ofTable 6 Treatment costs based on treatment time and proced
Median time to abdominal wall repair
Mean costs for initial hospital admission
Mean costs of porcine acellular dermal matrix Group 1 or synthetic mesh Gro
Mean costs of staged hernia repair (with second hospital stay)
Mean in-hospital days on readmission for hernia repair450cm2 (range 150 to 600cm2) was employed for the re-
pair. Primilene™ (Braun Melsungen, Melsungen, Germany)
was used nine times, Vipro II™ (Ethicon, Norderstedt,
Germany) was used twice, and TiMesh™ (Pfm Medical
AG, Cologne, Germany) was used three times. An onlay
repair was done in one patient, and in another the mesh
was placed between the internal and the external oblique
muscle. In the other 12 patients, a retrorectus sublay
repair was carried out. During the postoperative course,
one patient developed a hemorrhage and two patients
developed seromas. There were no mesh-related com-
plications in Group 2. All complications were treated
surgically. None of the patients required removal of the
mesh (Table 7).
Group 1 patients remained in the hospital a mean of
27.2 days, six days less than the combined stays of Group
2 patients (mean of 33 days; 26.1 days first admission plus
6.9 days second admission).
The median time between infection control and the
definitive abdominal wall repair was quite different for
the two study groups: 20 days (range 0 to 58 days) after
primary surgery in Group 1 and 352 days (range 70 to
3100 days) in Group 2 (Table 6). This was the time that
passed before patients in Group 2 were readmitted to
the hospital for hernia repair with synthetic mesh as part
of their planned two-stage procedure.
All surviving Group 1 patients (78.5 percent) were
clinically examined one year after hernia repair. There
was one recurrence after one year, resulting in a recur-
rence rate of 7.1 percent. All surviving Group 2 patients
(85.0 percent) were clinically examined a mean of six
years (range two to 10 years) after hernia repair. No hernia
recurrences were detected. There was one repair for recur-
rence one year after the staged repair in Group 2 patients
amounting to a recurrence rate of 7.1 percent for the
entire group, even though the duration of the observation
period was longer for this group.
Using German diagnosis-related group (DRG) pay-
ment rates, average hospital reimbursement was €21,542
in Group 1 and €20,089 in Group 2 for the first hospital
stay. There was an additional sum of €3180 for the
planned hernia repair carried out during the second
hospital admission in Group 2. In Group 1, there was a
mean sum of €2353 for the purchase of the PADM and
in Group 2 a mean sum of €450 for the purchase of theures
Group 1 Group 2
20 days (range 0–58 days) 352 days (range 30–3100 days)
€21,542 (range 2871–63,603) €20,089 (range 2300–60,962)
up 2 €2353 (range 1760–8000) €450 (range 180–720)
€3180 (range 2300–7427)
6.9 (range 3–10)
Figure 1 Open abdomen in a 78-year-old woman with a frozen abdomen and retracted fascial edges.
Schardey et al. Journal of Medical Case Reports 2014, 8:251 Page 5 of 10
http://www.jmedicalcasereports.com/content/8/1/251synthetic mesh. In both groups, the materials used for
reconstruction were considered to be included in the
DRG and not covered by separate reimbursements to
the hospital from insurance companies. The overall
costs in both groups were very similar and not increased
by the use of PADM.Figure 2 Results 12 months after surgery using a single-stage
procedure employing component separation to restore the
midline and reinforce it with porcine acellular dermal matrix in
a 78-year-old woman with an open abdomen (the same patient
as in Figure 1).Discussion
The results of this small, nonrandomized clinical study
suggest that the repair of contaminated abdominal wall
defects can either be accomplished with a staged proced-
ure or by delayed primary closure of the abdomen using
PADM. In this series, both techniques were successful at
one year after final repair, had acceptable complication
rates, and had recurrence rates of approximately 7 per-
cent. Despite the higher price of the PADM, the costs of
delayed primary closure of the abdomen using PADM
do not seem to be higher than the staged procedure
with synthetic mesh. The treatment strategy of closing
the abdomen with reinforcement of the fascial sutureFigure 3 Computed tomography scan of a patient with cancer
showing the non-crosslinked porcine acellular dermal matrix
(arrow) nine months after implantation.
Table 7 Surgical site occurrences after porcine acellular
dermal matrix or mesh placement
Group 1 Group 2
Deep wound infection 1 0
Seroma formation 1 2
Hematoma 1 1
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early restoration of the integrity of the abdominal wall,
saved in-hospital days, and eliminated the need for a
second costly surgical procedure.
We started to use PADM for abdominal wall recon-
struction because, in the United States, such materials
have been in extensive use for more than a decade [12].
These biologic tissue matrices were mostly used in con-
taminated fields, which has allowed for a one-stage repair
with no or little subsequent matrix removal [10,12,13].
Unfortunately, long-term results are still not available.
Kissane and Itani [12] point out that ventral incisional
hernia repair with these matrices continues to be plagued
by a high recurrence rate and complications. They also
suggest that prospective randomized trials are needed to
properly direct practice in the use of these matrices and
evaluate their ultimate value. Recently, additional ex-
perimental [14] and clinical evidence [15] has appeared
supporting the use of large-pore synthetic mesh in con-
taminated surgical fields. Slater and coworkers [16] car-
ried out an extensive review of clinical trials of biological
matrices and synthetic mesh. They concluded that: ‘In
view of the current evidence, biologic grafts have similar
results to synthetic mesh or autologous repair in eitherFigure 4 Histologic section (hematoxylin & eosin staining) of non-cro
implantation into a colorectal cancer patient under chemotherapy. Fi
are shown within the scaffold.clean, contaminated, or complicated ventral hernia repair’.
Nonetheless, guidelines for the use of synthetic material in
contaminated fields are not yet available, while PADM is
made for use in exactly that particular clinical setting
[10,12,13]. The authors consider it to be an advantage to
have a material that can be used to reinforce the repair of
a contaminated abdominal wall defect, does not have to
be removed in the case of infection, and causes no harm
to the bowel either by aggressive adhesion formation or
fistula development.Placement of the matrix
Key considerations for a successful outcome include the
ability to restore the structural as well as the functional
anatomy of the abdominal wall. This can be achieved
using the biological repair material in a sublay position
(either retrorectus or intraperitoneal) to reinforce the
reconstruction [13,17]. Bridging of defects by fixing the
matrix to the edges of the wound should be avoided and
is associated with a high failure rate [17,18]. The one
failure we observed was in a patient with a matrix bridg-
ing the defect. Due to the small number of patients, it is
not possible to draw valid conclusions, but we had the
impression that these patients tolerated the clearly less-
invasive intraperitoneal placement of the PADM better
than placement in the retrorectus sublay position. In the
nonrandomized Repair of Infected Contaminated Hernias
(RICH) study, 60 percent of the PADM was placed in the
intraperitoneal underlay position [10]. Further randomized
trials are needed to confirm the optimal placement of the
PADM.sslinked porcine acellular dermal matrix biopsy nine months after
broblasts (black arrow in white arrow) and blood vessels (white arrow)
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Repair of complex abdominal defects is also technically
quite demanding, especially when the repair is under-
taken 10 to 15 days after the primary surgery. Adhesions
may be severe, and a functional closure is often difficult
to achieve at this stage. These difficulties were illus-
trated by the occurrence of small bowel injuries in two
patients in Group 1. Nonetheless, the postoperative
course in both patients was uneventful. However, the
overall wound event rate was low, with the occurrence
of wound infection in only one patient in Group 1
(7 percent).
Results from the multicenter RICH study [10] reported
a wound event rate of 66 percent and an infection rate
of 30 percent at 24 months. One of many differences
between the current study and the RICH study is that
single-stage repairs were carried out almost exclusively
in the latter, which means that patients were admitted,
the wound was cleaned and the PADM (Strattice™) was
implanted at the end of the procedure. This was true
not only in the clean-contaminated cases (49 percent)
but even in the contaminated (49 percent) and dirty cases
(2 percent). In contrast to this in the present series, all
wounds in Group 1 were cleaned and conditioned with
NPWT to the point where granulation tissue covered the
surface, before PADM was used. This converted Grade 4
hernias to Grade 3 hernias (that is, those that ‘may be po-
tentially contaminated due to previous wound infection’)
[13]. The process of cleaning the wound to control the
focus of infection prolonged the time to closure (mean 20
days) and allowed for the formation of adhesions. The
intention had been to make the final repair safer by redu-
cing the risk for infection, but this unintentionally
increased adhesions and the risk for bowel injury and
associated contamination. In addition, the duration of
in-hospital stay and procedural costs increased. By gaining
more experience with PADM, the approach practiced in
the RICH study may be adopted in more cases in order to
save costs.
In both the RICH study and in our series, it was not
necessary to remove the PADM during the treatment of
surgical-site occurrences. However, the rate of recur-
rence in the RICH study was 19 percent after one year
and 28 percent after two years [10]. In the RICH study,
large Grade 3 and 4 hernias [12] were treated in patients
of whom 64 percent had undergone multiple hernia
repairs, one third had experienced previous wound in-
fections, and a quarter had a BMI greater than 30kg/m2.
Despite the fact that these were high-risk hernia
patients, the rate of recurrence may be related to the
surgical strategy and to the high rate of postoperative
wound events. And, of course, it is necessary to find out
what really happens to PADM in the presence of
infection.Choice of biological repair materials
Biological repair materials are a diverse and expanding
class with a wide range of different properties. There are
specific characteristics that are thought to contribute to
successful use, especially in the setting of contamination
or low-grade infection [13]. These properties include an
intact extracellular matrix and the ability to support tissue
regeneration through revascularization and cell repopula-
tion in a clinically relevant timeframe. It has been hypothe-
sized that resistance to infection for some biological repair
materials may be related to the ingrowth of cells and vas-
culature [19]. A number of animal studies have shown that
some crosslinking processes may damage the extracellular
matrix, which may have a negative impact on the host re-
sponse to the repair material [20] and prevent ingrowth of
fibroblasts into the matrix [21]. Further research supports
the theory that the ability of the immune system to
recognize the matrix as ‘self ’ is important for an optimal
host response as a negative or poor recognition may result
in absorption or encapsulation of the matrix [20,22]. An
in vitro study has shown that a non-crosslinked tissue
matrix may elicit a more moderate mononuclear cell
response than crosslinked matrices, suggesting improved
integration into host tissue [23].
For the purposes of this study, Strattice™ was selected
for the repair of contaminated abdominal wall defects. It
is a non-crosslinked PADM and has shown good results
in experimental studies in nonhuman primates [11]. A
CT scan at nine months post-surgery in a 71-year-old
patient who had undergone delayed primary closure
with Strattice™ in our series demonstrated the physical
presence of the implanted matrix (Figure 3), while histo-
logical examination showed fibroblasts and vascular in-
growth (Figure 4).
Selection process and outcomes
The groups were quite similar with respect to demograph-
ics, type of planned or emergency surgery, and postopera-
tive complications. Patients from Group 1 were chosen
due to the fact that the PADM had been used to repair the
contaminated abdominal wall defect. The historical con-
trol group (Group 2) was selected on the basis of having
had a staged repair of a Grade 3 [13] contaminated ab-
dominal wall hernia, meaning that they were admitted to
the hospital twice. Simple suture repair had been carried
out in most of them in the presence of contamination.
This strategy may result in a high rate of incisional hernia,
reaching 69 percent after 10 years in some studies [24].
The duration between primary surgery for infection and
final repair of the hernia averaged one year. This was one
of the major differences between the two groups. Even
though we do not have systematic quality-of-life data of
our patients, it is well known that incisional hernias are a
source of discomfort and can limit physical ability.
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a reconstructed and stable abdominal wall approximately
20 days after initial treatment for infection. This is a
major advantage. Early functional restitution of the ab-
dominal wall was important to these patients, as evi-
denced by patient reports upon follow-up examinations.
One year results were good (Figure 2), with only one
recurrence likely due to poor technique (that is, bridging
the defect with insufficient overlap [17,18]). There were
two deaths in Group 1, one due to persistent sepsis after
bowel perforation, the other due to pneumonia. Both
deaths were unrelated to the PADM.
Comparison of costs
The in-hospital costs of the initial hospital admission for
both groups were similar as calculated according to the
German DRG system (Table 6). However, in Group 2
patients treated with the staged repair, there was ap-
proximately one year between procedures and there is
no documentation of the costs incurred during this
period.
The costs of the incisional hernia repair during the
second admission in Group 2 patients, including adjust-
ment for comorbidities and complications as well as the
in-hospital stay for an average of 6.9 days, amounted to
a mean cost of €3180 (German DRG). These costs were
higher than the mean cost of €2353 per patient for the
PADM used to restore the functional and anatomical in-
tegrity of the abdominal wall in Group 1 patients during
the initial hospital stay. The PADM size used in the major-
ity of cases was 16×7cm, which represented a cost savings
compared with the larger 20×20cm size used in 86 percent
of patients in the RICH Study [10]. The costs for synthetic
mesh or biologic matrices are not reimbursed separately
by German health insurance companies.
Limitations
The limitations of this report are its retrospective, single-
institutional design, the selection of a historic controlTable 8 Ventral Hernia Working Group assessment of incision
definitions of grades
Grade 1 Grade 2 Grade 3
Low risk of surgical-site
occurrences





due to a p
of a stoma
gastrointes
No history of wound
infection




Adapted with permission from Surgery, 148, Breuing K, Butler CE, Ferzoco S, et al. In
regarding the grading and technique of repair, 544–558, ©2010 [13].group, modest sample size, and a relatively short follow-
up period in these high-risk hernia patients.
Conclusions
The use of PADM is a new concept in medicine and offers
a means to treat contaminated abdominal wall defects as
well as defects at high risk for infection. The results of this
study suggest on short-term observation that delayed
primary closure using non-crosslinked PADM provides
an equally safe and effective alternative to conventional
staged repair of Grade 3 contaminated abdominal wall
defects. PADM may offer faster recovery times and re-
sult in earlier restoration of abdominal wall function,
thus reducing overall duration of physical impairment
without increasing the costs of treatment, despite the
cost of the biological scaffold. The reduction in the num-
ber of admissions and of in-hospital days achievable by
using PADM may have a greater impact on costs in other
health-care systems outside of Germany. Randomized
trials are needed clarify these open questions.
Methods
Under the approved Ludwig Maximilians University
(LMU) of Munich ethics committee protocol, records of
patients with contaminated abdominal wall defects treated
at the Department of Surgery at Agatharied Academic
Teaching Hospital of the LMU were reviewed retro-
spectively. The hospital database was searched using the
Operations and Procedures (OPC) and International
Statistical Classification of Diseases and Related Health
Problems (ICD) codes for incisional hernias, burst abdo-
men, emergency surgery for perforated bowel, peritonitis,
and abdominal wall infection documented between 1999
and 2010. Classification of the abdominal defect was made
according to the Ventral Hernia Working Group (VHWG)
recommendations [13] (Table 8) from the United States,
where the use of biologic matrices is more common.
In Group 1, 13 consecutive patients with 14 Grade 3
abdominal wall hernias had delayed primary closure ofal ventral hernias for risk of surgical site occurrences:
Grade 4
High risk of surgical-site occurrences
at are potentially contaminated
revious wound infection, presence
, or violation of the
tinal tract
Wounds with active infection, such
as septic dehiscence or the presence
of an infected synthetic mesh
cisional ventral hernias: review of the literature and recommendations
Table 9 Factors defining classification of Grade 3
contaminated abdominal wall hernias*
Group 1 Group 2
Violation of the intestinal tract 10 11
Stoma present 8 7
History of mesh infection 1 0
Existing open wound 8 8
*Some patients presented with more than one factor.
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during a single hospital admission (during the study
period, one patient was operated on twice due to tumor
progression, both times using the same material and
technique). In Group 2, 14 patients with abdominal wall
defects classified as Grade 3 abdominal wall hernias
during initial hospital admission were selected from the
database. Patients in Group 2 received conventional two-
stage repair of an abdominal wall defect (that is, treatment
of the contaminated abdominal wall during the first
hospital admission and an incisional hernia repair with
synthetic mesh during the second hospital admission).
All patients in both groups met one or more criteria for
classification as a Grade 3 hernia (Table 9). In purulent
infection, as described for Grade 4 hernias, no recon-
struction was carried out before the wound was con-
verted to a Grade 3 hernia using debridement, washout,
and NPWT.
The clinical course, facility costs, and patient outcomes
were compared between groups. Demographics, comor-
bidities, BMI, ASA score, surgical notes, complications,
and follow-up data were evaluated. Surgical data included
date of surgery, indications for surgery, type of surgery
(emergency or planned), fascial defect location, charac-
teristics, defect size, mesh type and size, and number of
surgical procedures.Surgical control of intra-abdominal and abdominal wall
infection
Intra-abdominal infections resulting from intestinal
perforations or other complications in both groups were
treated by suturing, resection, or by creating diversion
colostomies or ileostomies. The creation of high-risk
anastomoses was avoided in most cases. In addition, an
abdominal washout was included as a standard procedure.
Relaparotomies and additional washouts were carried out
when indicated. In severe cases, intra-abdominal NPWT
was used to temporarily close the abdomen.
Sharp debridement of devitalized or infected tissue to
reduce the wound bioburden was carried out at the level
of the abdominal wall. Pulse lavage was applied in six
cases (three in each group) to clean contaminated tissue.
The majority of cases (n=20) received NPWT to thewound only until healthy granulation tissue covered the
wound surface prior to closure.
Group 1: delayed primary closure with PADM during one
hospital admission
Fascial closure using a sublay reinforcement with PADM
was performed in 13 cases. One patient underwent an
emergency parastomal hernia repair using PADM with
an onlay technique to reinforce the reconstruction. PADM
was fixed to fascial structures with permanent Prolene size
0 sutures in all cases. PADM was placed under moderate
tension with at least 3cm overlap beyond the fascial mar-
gins. This preset tension was used to minimize the stress
to the fascial suture line [13]. Component separation tech-
nique, as described by Ramirez et al. [25], was performed
to achieve a functional reconstruction of the linea alba.
PADM was used in all 14 procedures.
Group 2: staged repair of contaminated abdominal wall
defects during two hospital admissions
Group 2 patients had undergone treatment to control
intra-abdominal complications and infection of the ab-
dominal wall. Four patients had been discharged with an
abdominal wall defect using a skin-only repair to close the
abdomen; in 10 patients, a hernia developed after a con-
taminated Grade 3 abdominal wall defect had been closed
by suture repair. Patients were readmitted to the hospital
for hernia repair with synthetic mesh several months after
their first admission. Midline closure was the goal, with
use of component separation as necessary.
Consent
Written informed consent was obtained from the patients
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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